Common Stock, Shares, Outstanding of PROVECTUS BIOPHARMACEUTICALS, INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
PROVECTUS BIOPHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • PROVECTUS BIOPHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 420,279,879, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 420,279,879 0 0% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 420,279,879 +757,760 +0.18% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q4 2024 420,279,879 +757,760 +0.18% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 420,279,879 +757,760 +0.18% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 419,522,119 +25,000 +0.01% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 419,522,119 +25,000 +0.01% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 419,522,119 +75,000 +0.02% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 419,522,119 +25,000 +0.01% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 419,497,119 +50,000 +0.01% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 419,497,119 +50,000 +0.01% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 419,447,119 0 0% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 419,497,119 +50,000 +0.01% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 419,447,119 +15,665,082 +3.9% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 419,447,119 +15,890,082 +3.9% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 419,447,119 +20,640,082 +5.2% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 419,447,119 +22,590,082 +5.7% 30 Sep 2021 10-Q 10 Nov 2021 2021 FY
Q2 2021 403,782,037 +13,067,562 +3.3% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 403,557,037 +12,867,562 +3.3% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 398,807,037 +8,917,562 +2.3% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 396,857,037 +8,280,062 +2.1% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 390,714,475 +5,808,357 +1.5% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 390,689,475 +5,974,947 +1.6% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 389,889,475 +5,274,947 +1.4% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 388,576,975 +5,075,947 +1.3% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 384,906,118 +1,795,090 +0.47% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 384,714,528 +5,826,338 +1.5% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 384,614,528 +13,653,077 +3.7% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 383,501,028 +12,763,885 +3.4% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 383,111,028 +12,756,385 +3.4% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 378,888,190 +8,533,547 +2.3% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 370,961,451 +6,188,154 +1.7% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 370,737,143 +126,841,791 +52% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 370,354,643 +157,525,291 +74% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 370,354,643 +157,525,291 +74% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 364,773,297 +159,794,197 +78% 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q3 2016 243,895,352 +39,258,216 +19% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 212,829,352 +8,271,093 +4% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 212,829,352 +26,857,193 +14% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 204,979,100 +20,182,825 +11% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 204,637,136 +24,337,397 +13% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 204,558,259 +27,919,820 +16% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 185,972,159 +12,846,187 +7.4% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 184,796,275 +25,044,551 +16% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 180,299,739 +40,325,408 +29% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 176,638,439 +48,013,824 +37% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 173,125,972 +48,575,012 +39% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 159,751,724 +41,323,799 +35% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 139,974,331 +29,377,533 +27% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 128,624,615 +18,027,817 +16% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 124,550,960 +13,614,979 +12% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 118,427,925 +7,831,127 +7.1% 31 Dec 2012 10-K 13 Mar 2014 2013 FY
Q3 2012 110,596,798 +955,940 +0.87% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 110,596,798 +1,937,197 +1.8% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 110,935,981 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 110,596,798 +19,298,915 +21% 31 Dec 2011 10-K 14 Mar 2013 2012 FY
Q3 2011 109,640,858 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 108,659,601 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q4 2010 91,297,883 31 Dec 2010 10-K 14 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.